EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
59.50
-0.50 (-0.83%)
At close: Nov 25, 2025
3.48% (1Y)
| Market Cap | 106.26M |
| Revenue (ttm) | 9.71M |
| Net Income (ttm) | 1.30M |
| Shares Out | 1.79M |
| EPS (ttm) | 0.73 |
| PE Ratio | 81.86 |
| Forward PE | n/a |
| Dividend | 1.83 (3.08%) |
| Ex-Dividend Date | Jun 16, 2025 |
| Volume | 383 |
| Average Volume | 94 |
| Open | 60.00 |
| Previous Close | 60.00 |
| Day's Range | 59.50 - 60.00 |
| 52-Week Range | 55.00 - 65.50 |
| Beta | -0.04 |
| RSI | 38.16 |
| Earnings Date | Feb 10, 2026 |